U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ETBX-051
Common Name English
AN ADENOVIRUS VECTOR CANCER VACCINE COMPOSED OF A REPLICATION-DEFECTIVE, SER OTYPE 5 ADENOVIRUS (AD5) THAT HAS BEEN MODIFIED BY REMOVAL OF THE E1, E2B AND E3 GENES AND INSERTION OF A MODIFIED HUMAN BRACHYURY PROTEIN-EXPRESSING GENE
Common Name English
ADENOVIRAL BRACHYURY VACCINE ETBX-051
Common Name English
Code System Code Type Description
FDA UNII
BPG11IF0HW
Created by admin on Sat Dec 16 14:34:35 UTC 2023 , Edited by admin on Sat Dec 16 14:34:35 UTC 2023
PRIMARY
NCI_THESAURUS
C143034
Created by admin on Sat Dec 16 14:34:35 UTC 2023 , Edited by admin on Sat Dec 16 14:34:35 UTC 2023
PRIMARY
CAS
2171537-82-7
Created by admin on Sat Dec 16 14:34:35 UTC 2023 , Edited by admin on Sat Dec 16 14:34:35 UTC 2023
PRIMARY
ACTIVE MOIETY
ETBX-051
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966